Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
17%(1 trials)

Phase Distribution

Ph phase_3
1
13%
Ph not_applicable
6
75%
Ph phase_2
1
13%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
1(12.5%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(6)
Other(2)

Detailed Status

Completed6
unknown2

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (12.5%)
Phase 31 (12.5%)
N/A6 (75.0%)

Trials by Status

unknown225%
completed675%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
RADIATION
Total Trials
8